These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19252280)

  • 21. Effects of Yokukansan, a Japanese Kampo Medicine for Symptoms Associated Autism Spectrum Disorder.
    Wake R; Miyaoka T; Furuya M; Hashioka S; Horiguchi J
    CNS Neurol Disord Drug Targets; 2016; 15(5):551-63. PubMed ID: 27071791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Basic Study of Drug-Drug Interaction between Memantine and the Traditional Japanese Kampo Medicine Yokukansan.
    Matsumoto T; Sekiguchi K; Kawakami Z; Watanabe J; Mizoguchi K; Ikarashi Y; Yamamoto M
    Molecules; 2018 Dec; 24(1):. PubMed ID: 30597998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of behavioral and psychological symptoms of Alzheimer-type dementia with Yokukansan in clinical practice.
    Hayashi Y; Ishida Y; Inoue T; Udagawa M; Takeuchi K; Yoshimuta H; Kiue K; Ninomiya Y; Kawano J; Sameshima T; Kawahara T; Goto I; Shudo K; Kurayama S; Nakamura J; Okahara K; Mitsuyama Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):541-5. PubMed ID: 20184936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of yokukansan, a traditional Japanese medicine, on memory disturbance and behavioral and psychological symptoms of dementia in thiamine-deficient rats.
    Ikarashi Y; Iizuka S; Imamura S; Yamaguchi T; Sekiguchi K; Kanno H; Kawakami Z; Yuzurihara M; Kase Y; Takeda S
    Biol Pharm Bull; 2009 Oct; 32(10):1701-9. PubMed ID: 19801831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Traditional Japanese Herbal Medicine Yokukansan Targets Distinct but Overlapping Mechanisms in Aged Mice and in the 5xFAD Mouse Model of Alzheimer's Disease.
    Kaushik R; Morkovin E; Schneeberg J; Confettura AD; Kreutz MR; Senkov O; Dityatev A
    Front Aging Neurosci; 2018; 10():411. PubMed ID: 30631278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Yokukansan Ameliorates Hippocampus-Dependent Learning Impairment in Senescence-Accelerated Mouse.
    Azuma K; Toyama T; Katano M; Kajimoto K; Hayashi S; Suzuki A; Tsugane H; Iinuma M; Kubo KY
    Biol Pharm Bull; 2018; 41(10):1593-1599. PubMed ID: 30270329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Partial agonistic effect of yokukansan on human recombinant serotonin 1A receptors expressed in the membranes of Chinese hamster ovary cells.
    Terawaki K; Ikarashi Y; Sekiguchi K; Nakai Y; Kase Y
    J Ethnopharmacol; 2010 Feb; 127(2):306-12. PubMed ID: 19913081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Geissoschizine methyl ether, an alkaloid in Uncaria hook, is a potent serotonin ₁A receptor agonist and candidate for amelioration of aggressiveness and sociality by yokukansan.
    Nishi A; Yamaguchi T; Sekiguchi K; Imamura S; Tabuchi M; Kanno H; Nakai Y; Hashimoto K; Ikarashi Y; Kase Y
    Neuroscience; 2012 Apr; 207():124-36. PubMed ID: 22314317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Japanese Angelica acutiloba root and yokukansan increase hippocampal acetylcholine level, prevent apoptosis and improve memory in a rat model of repeated cerebral ischemia.
    Nogami-Hara A; Nagao M; Takasaki K; Egashira N; Fujikawa R; Kubota K; Watanabe T; Katsurabayashi S; Hatip FB; Hatip-Al-Khatib I; Iwasaki K
    J Ethnopharmacol; 2018 Mar; 214():190-196. PubMed ID: 29269276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anxiolytic effect of a herbal medicine, yokukansan, in aged rats: involvement of serotonergic and dopaminergic transmissions in the prefrontal cortex.
    Mizoguchi K; Tanaka Y; Tabira T
    J Ethnopharmacol; 2010 Jan; 127(1):70-6. PubMed ID: 19799980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antistress effects of Kampo medicine "Yokukansan" via regulation of orexin secretion.
    Katahira H; Sunagawa M; Watanabe D; Kanada Y; Katayama A; Yamauchi R; Takashima M; Ishikawa S; Hisamitsu T
    Neuropsychiatr Dis Treat; 2017; 13():863-872. PubMed ID: 28360524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerability of risperidone, yokukansan, and fluvoxamine for the treatment of behavioral and psychological symptoms of dementia: a blinded, randomized trial.
    Teranishi M; Kurita M; Nishino S; Takeyoshi K; Numata Y; Sato T; Tateno A; Okubo Y
    J Clin Psychopharmacol; 2013 Oct; 33(5):600-7. PubMed ID: 23948783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-allergic mechanisms of Japanese herbal medicine, yokukansan on mast cells.
    Yamamura K; Kato S; Kato TA; Mizoguchi Y; Monji A; Kanba S; Furue M; Takeuchi S
    J Dermatol; 2014 Sep; 41(9):808-14. PubMed ID: 25156212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ameliorative effect of Yokukansan on social isolation-induced aggressive behavior of zinc-deficient young mice.
    Tamano H; Kan F; Oku N; Takeda A
    Brain Res Bull; 2010 Nov; 83(6):351-5. PubMed ID: 20813168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Yokukansan inhibits morphine tolerance and physical dependence in mice: the role of α₂A-adrenoceptor.
    Nakagawa T; Nagayasu K; Nishitani N; Shirakawa H; Sekiguchi K; Ikarashi Y; Kase Y; Kaneko S
    Neuroscience; 2012 Dec; 227():336-49. PubMed ID: 23069764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Effect of Yokukansan, a Traditional Herbal Preparation Used for the Behavioral and Psychological Symptoms of Dementia, on the Drug-Metabolizing Enzyme Activities in Healthy Male Volunteers.
    Soraoka H; Oniki K; Matsuda K; Ono T; Taharazako K; Uchiyashiki Y; Kamihashi R; Kita A; Takashima A; Nakagawa K; Yasui-Furukori N; Kadowaki D; Miyata K; Saruwatari J
    Biol Pharm Bull; 2016; 39(9):1468-74. PubMed ID: 27582327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycyrrhiza and Uncaria Hook contribute to protective effect of traditional Japanese medicine yokukansan against amyloid β oligomer-induced neuronal death.
    Kanno H; Kawakami Z; Iizuka S; Tabuchi M; Mizoguchi K; Ikarashi Y; Kase Y
    J Ethnopharmacol; 2013 Aug; 149(1):360-70. PubMed ID: 23838475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Yokukansan, a traditional Japanese medicine, decreases head-twitch behaviors and serotonin 2A receptors in the prefrontal cortex of isolation-stressed mice.
    Ueki T; Mizoguchi K; Yamaguchi T; Nishi A; Sekiguchi K; Ikarashi Y; Kase Y
    J Ethnopharmacol; 2015 May; 166():23-30. PubMed ID: 25732836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Yokukansan for the Treatment of Idiopathic Rapid Eye Movement Sleep Behavior Disorder: A Retrospective Analysis of Consecutive Patients.
    Matsui K; Sasai-Sakuma T; Ishigooka J; Nishimura K; Inoue Y
    J Clin Sleep Med; 2019 Aug; 15(8):1173-1178. PubMed ID: 31482840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Yokukansan and Yokukansankachimpihange Ameliorate Aggressive Behaviors in Rats with Cholinergic Degeneration in the Nucleus Basalis of Meynert.
    Tabuchi M; Mizuno K; Mizoguchi K; Hattori T; Kase Y
    Front Pharmacol; 2017; 8():235. PubMed ID: 28491038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.